Neural tissue engineering using embryonic and induced pluripotent stem cells.
about
Induced Pluripotent Stem Cell Therapies for Cervical Spinal Cord InjuryFabrication of poly (ϵ-caprolactone) microfiber scaffolds with varying topography and mechanical properties for stem cell-based tissue engineering applicationsHuman conditionally immortalized neural stem cells improve locomotor function after spinal cord injury in the rat.Protoplasmic astrocytes enhance the ability of neural stem cells to differentiate into neurons in vitro.Advances in regenerative therapies for spinal cord injury: a biomaterials approach.Morphogenesis of human embryonic stem cells into mature neurons under in vitro culture conditionsSpatiotemporal evolution of early innate immune responses triggered by neural stem cell grafting.Amelioration of motor/sensory dysfunction and spasticity in a rat model of acute lumbar spinal cord injury by human neural stem cell transplantation.Conditionally immortalized stem cell lines from human spinal cord retain regional identity and generate functional V2a interneurons and motorneurons.Regenerative therapies for central nervous system diseases: a biomaterials approach.Emerging Biofabrication Strategies for Engineering Complex Tissue Constructs.Neurogenic and neuro-protective potential of a novel subpopulation of peripheral blood-derived CD133+ ABCG2+CXCR4+ mesenchymal stem cells: development of autologous cell-based therapeutics for traumatic brain injury.Functionalizing Ascl1 with Novel Intracellular Protein Delivery Technology for Promoting Neuronal Differentiation of Human Induced Pluripotent Stem Cells.Mechanically stable fibrin scaffolds promote viability and induce neurite outgrowth in neural aggregates derived from human induced pluripotent stem cells.Engineering personalized neural tissue using functionalized transcription factors.Modeling the behavior of human induced pluripotent stem cells seeded on melt electrospun scaffolds.Fabrication of Hemin-Doped Serum Albumin-Based Fibrous Scaffolds for Neural Tissue Engineering Applications.Cell differentiation on disk- and string-shaped hydrogels fabricated from Ca(2+) -responsive self-assembling peptides.Engineering personalized neural tissue by combining induced pluripotent stem cells with fibrin scaffolds.Nanoparticles for Stem-Cell Engineering
P2860
Q26748907-2FB92E90-11E3-45E6-AA4A-52790203BCE5Q29391984-05023B71-8B5A-4D2D-8793-0D739854A554Q30541296-561BF247-5C7D-47EE-B56E-AF73220A2DC4Q34302435-463FF9B7-A46B-4A1E-A134-76D90AB1FD1CQ35746310-25AC19A2-6E23-4E5D-B981-F50AE0709BB8Q36210878-4CFD3260-C5C8-4DF7-A890-E1766BA4885AQ36633053-012CD136-333A-44AD-ADB6-51D888713D0AQ36998177-8723337C-9B5D-42B2-84C2-769FFC4C744AQ36998308-5D9C90C3-C0C1-4B10-8EC7-669A149999ADQ38133954-EF62D0EB-386A-48BC-8B8B-7BB9EDA9DA7BQ39215980-DAAA220C-D493-4C77-8377-51BAE8DA7628Q39216274-CC89B2D0-F772-4335-9F49-580BC638F2ABQ40772027-2F88E82C-EAB3-445E-8F9C-39887F86CC30Q41109305-9627CF3D-4EAB-4A70-B72A-C3B8A88EEAB1Q41808646-E90C15AB-F47B-47F6-9154-B876EFD3F1E7Q42654196-51B2071B-4102-41C8-8864-1B11E3CF4ECFQ48142296-47F736C8-E182-42AD-A8B0-9A5D5FD0381AQ51672634-5EFEED47-9B11-4149-8D9E-4C0C601EC58AQ51831198-F7071AC3-AC98-4FE2-9242-E5D01C09CB04Q57340466-232F4253-0472-4B02-BF5A-452324BE1BC6
P2860
Neural tissue engineering using embryonic and induced pluripotent stem cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Neural tissue engineering using embryonic and induced pluripotent stem cells.
@ast
Neural tissue engineering using embryonic and induced pluripotent stem cells.
@en
type
label
Neural tissue engineering using embryonic and induced pluripotent stem cells.
@ast
Neural tissue engineering using embryonic and induced pluripotent stem cells.
@en
prefLabel
Neural tissue engineering using embryonic and induced pluripotent stem cells.
@ast
Neural tissue engineering using embryonic and induced pluripotent stem cells.
@en
P2860
P921
P356
P1476
Neural tissue engineering using embryonic and induced pluripotent stem cells
@en
P2093
Stephanie M Willerth
P2860
P2888
P356
10.1186/SCRT58
P577
2011-04-15T00:00:00Z
P5875
P6179
1014450780